Addfcfba 0eb4 11ef Ac47 7c1e520e223c Header

Prepared For
Ms Shimla Devi
F 52
fa lse
Name Patient ID Gender Age

Ms Shimla Devi 1_8222497 F 52
Health Summary
BLOOD COUNTS
Everything looks good
LIPID PROFILE
KIDNEY PROFILE
LIVER PROFILE
ANEMIA STUDIES

Patient Name : Ms Shimla Devi
DOB/Age/Gender : 52 Y/Female Sample Collected : May 10, 2024, 06:46 AM
Patient ID / UHID : 1_8222497/RCL7445637 Report Date : May 10, 2024, 01:30 PM
Referred By : Self Barcode No : HY604389
Sample Type : Whole blood EDTA Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
Vital Screening Package

Complete Blood Count (CBC)
RBC Parameters
Hemoglobin 13.6 g/dL 12.0 - 15.0
Spectrophotometry
RBC Count 4.9 10^6/µl 3.8 - 4.8
Electrical impedance
PCV 41.1 % 36 - 46
Calculated
MCV 83.1 fl 83 - 101
Calculated
MCH 27.5 pg 27 - 32
Calculated
MCHC 33.1 g/dL 31.5 - 34.5
Calculated
RDW (CV) 14.5 % 11.6 - 14.0
Calculated
RDW-SD 31.8 fl 35.1 - 43.9
Calculated
WBC Parameters
TLC 6.7 10^3/µl 4 - 10
Electrical impedance and microscopy
Differential Leucocyte Count
Neutrophils 51.4 % 40-80
Flow-cytometry DHSS
Lymphocytes 37.1 % 20-40
Flow-cytometry DHSS
Monocytes 8.4 % 2-10
Flow-cytometry DHSS
Eosinophils 2.9 % 1-6
Flow-cytometry DHSS
Basophils 0.2 % <2
Flow-cytometry DHSS
Absolute Leukocyte Counts
Neutrophils. 3.44 10^3/µl 2-7
Lymphocytes. 2.49 10^3/µl 1-3
Calculated
Monocytes. 0.56 10^3/µl 0.2 - 1.0
Calculated
Eosinophils. 0.19 10^3/µl 0.02 - 0.5
Calculated
Basophils. 0.01 10^3/µl 0.02 - 0.5
Calculated
Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H-55, Sector-63, Noida, Uttar Pradesh - 201301
Page 1 of 11
Platelet Parameters
Platelet Count 155 10^3/µl 150 - 410
Electrical impedance and microscopy
Mean Platelet Volume (MPV) 11.4 fL 9.3 - 12.1
Calculated
PCT 0.2 % 0.17 - 0.32
Calculated
PDW 21.9 fL 8.3 - 25.0
Calculated
P-LCR 47.1 % 18 - 50
Calculated
P-LCC 63 % 44 - 140
Calculated
Mentzer Index 16.96 % > 13
Calculated
Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.

Page 2 of 11
Erythrocyte Sedimentation Rate (ESR)
ESR - Erythrocyte Sedimentation Rate 12 mm/hr 0 - 19

MODIFIED WESTERGREN
Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.
AGE MALE FEMALE

1 DAY 0-2 0-2
2 - 7 DAYS 0-4 0-4
8 - 14 DAYS 0-17 0-17
15 DAYS - 17 YEARS 0-20 0-20
18 - 50 YEARS 0-10 0-12
51- 60 YEARS 0-12 0-19
61 - 70 YEARS 0-14 0-20
71 - 100 YEARS 0-30 0-35
Reference- Dacie and lewis practical hematology

Page 3 of 11
Referred By : Self Barcode No : ZC707328
Sample Type : FLUORIDE F Report Status : Final Report
Free Glucose Fasting Test

Glucose Fasting (BSF)
Glucose Fasting 100.7 mg/dL <100

Hexokinase
Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes ≥126
Reference : American Diabetes Association
Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels (hyperglycemia)
may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders. Decreased glucose
levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.
Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

Page 4 of 11
Sample Type : Serum Report Status : Final Report

Liver Function Test (LFT)
Bilirubin Total 0.57 mg/dL 0.2 - 1.2

Diazonium Salt
Bilirubin Direct 0.23 mg/dL 0.0 - 0.5
Diazo Reaction
Bilirubin Indirect 0.34 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)
SGOT/AST 34 U/L 11 - 34
NADH (without P-5-P)
SGPT/ALT 27.04 U/L < 34
NADH (without P-5-P)
SGOT/SGPT Ratio 1.26 - -
Calculated
Alkaline Phosphatase 105 U/L 46 – 122
Para-nitrophenyl phosphate (p-NPP)
Total Protein 6.85 g/dL 6.4 - 8.3
Biuret
Albumin 4.27 g/dL 3.5 - 5.2
Colorimetric BCG
Globulin 2.58 g/dL 2.3 - 3.5
Calculation (T.P - Albumin)
Albumin :Globulin Ratio 1.66 - 1.0 - 2.1
Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) 28.07 U/L < 38
L-gamma-glutamyl-3-carboxy-4-nitroanilide substra
Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood clotting proteins, and
performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical reactions. When liver cells are damaged or
destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood tests Liver tests check the blood for two main liver enzymes.
Aspartate aminotransferase (AST),SGOT: The AST enzyme is also found in muscles and many other tissues besides the liver. Alanine aminotransferase (ALT),
SGPT: ALT is almost exclusively found in the liver. If ALT and AST are found together in elevated amounts in the blood, liver damage is most likely present. Alkaline
Phosphatase and GGT: Another of the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of small tubes
(ducts), and is eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise:Alkaline
phosphatase Gamma-utamyl transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase is by far the most
commonly tested of the three. If alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present. Bile flow problems can be due to a
problem in the liver, the gallbladder, or the tubes connecting them. Proteins are important building blocks of all cells and tissues. Proteins are necessary for your
body's growth, development, and health. Blood contains two classes of protein, albumin and globulin. Albumin proteins keep fluid from leaking out of blood
vessels. Globulin proteins play an important role in your immune system. Low total protein may indicate: 1.bleeding 2.liver disorder 3.malnutrition
4.agammaglobulinemia High Protein levels 'Hyperproteinemia: May be seen in dehydration due to inadequate water intake or to excessive water loss (eg, severe
vomiting, diarrhea, Addison's disease and diabetic acidosis) or as a result of increased production of proteins Low albumin levels may be caused by: 1.A poor diet
(malnutrition). 2.Kidney disease. 3.Liver disease. High albumin levels may be caused by: Severe dehydration.

Page 5 of 11
Kidney Function Test (KFT)
Blood Urea 24.06 mg/dL 21 - 43

Urease
Creatinine 0.54 mg/dL 0.5 - 1.1
Kinetic Alkaline Picrate
Bun 11.24 mg/dL 6 - 20
Calculated
Bun/Creatinine Ratio 20.81
Calculated
Urea / Creatinine Ratio 44.56
Uric Acid 3.64 mg/dL 2.5 - 6.2
Uricase
Calcium Serum 8.58 mg/dL 8.4 - 10.2
Arsenazo III
Phosphorus 4.42 mg/dL 2.3 - 4.7
Phosphomolybdate
Sodium 142 mmol/L 136 - 145
ISE-Indirect
Potassium 3.62 mmol/L 3.5 - 5.1
ISE-Indirect
Chloride 104 mmol/L 98 - 107
ISE-Indirect
Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning.Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual
(chronic) declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples.A number of symptoms may indicate
a problem with your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful urination,swelling
in the hands and feet due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring simultaneously, these
symptoms suggest that your kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes (sodium,potassium,and chloride)
are present in the human body and the balancing act of the electrolytes in our bodies is essential for normal function of our cells and organs. There has to be a
balance.Ionized calcium this test if you have signs of kidney or parathyroid disease. The test may also be done to monitor progress and treatment of these
diseases.

Page 6 of 11
Lipid Profile
Total Cholesterol 179 mg/dL <200

Enzymatic
Triglycerides 148 mg/dL <150
Glycerol phosphate oxidase
HDL Cholesterol 49 mg/dL > 40
Accelerator Selective Detergent
Non HDL Cholesterol 130 mg/dL <130
Calculated
LDL Cholesterol 100.4 mg/dL <100
Calculated
V.L.D.L Cholesterol 29.6 mg/dL < 30
Calculated
Chol/HDL Ratio 3.65 Ratio -
Calculated
HDL/ LDL Ratio 0.49 Ratio -
Calculated
LDL/HDL Ratio 2.05 Ratio -
Calculated
Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.
National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159
Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220
HDL Cholesterol
Low High
<40 >=60
Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.
Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C
Extreme risk group
<or = 50 mg/dl or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia

Page 7 of 11
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors
Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors
1. Age >/=45 years in Males & >/= 55
3. Current Cigarette smoking or tobacco use
years in Females
2. Family history of premature ASCVD 4. High blood pressure
5. Low HDL
Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.
Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)
Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160
* After an adequate non-pharmacological intervention for at least 3 months.
References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of India.
Current Vascular Pharmacology,2022,20,134-155.

Page 8 of 11
Alpha Fetoprotein (AFP), Tumor Marker
AFP (ALPHA FETOPROTEIN), TUMOR MARKER 7.24 ng/mL Up to 8.78

CMIA
Interpretation:
1. This test is not recommended to screen cancers in the general population.
2. False negative/positive results are observed in patients receiving mouse monoclonal antibodies for diagnosis or therapy.
3. Use of AFP as a tumor marker is not recommended in pregnant females.
4. AFP values regardless of levels should not be interpreted as absolute evidence for the presence or absence of disease. All values
should be correlated with clinical findings and results of other investigations.
Clinical Use
1. Useful for determining prognosis and monitoring therapy for Hepatocellular carcinoma. Level of AFP is a prognostic indicator of
survival. Elevated AFP and serum bilirubin levels in these patients is associated with shorter survival time.
2. An aid in the management of Germ cell (Non-Seminomatous) tumors. Measurement of AFP levels in combination with HCG levels
are useful in classifying and staging Germ cell tumors
3. To predict tumor recurrence/presence of residual tumor
Increased Levels
1. Germ cell (Non-Seminomatous) tumors
2. Primary hepatocellular carcinoma (70%)
3. Teratocarcinoma
4. Gastrointestinal tract cancers with or without liver metastasis
5. Benign hepatic conditions like Acute Viral Hepatitis, Chronic active hepatitis and Cirrhosis
6. Ataxia telangiectasia
7. Hereditary tyrosinemia

Page 9 of 11
Referred By : Self Barcode No : YA620449
Sample Type : Spot Urine Report Status : Final Report

Urine Routine and Microscopic Examination
Physical Examination
Volume 20 mL -
Colour Pale yellow - Pale yellow
Transparency Slightly Hazy - Clear
Deposit Present - Absent
Chemical Examination
Reaction (pH) 6 - 4.5 - 8.0
Double Indicator
Specific Gravity 1.025 - 1.010 - 1.030
Ion Exchange
Urine Glucose (sugar) Negative - Negative
Oxidase / Peroxidase
Urine Protein (Albumin) Negative - Negative
Acid / Base Colour Excahnge
Urine Ketones (Acetone) Negative - Negative
Legals Test
Blood Negative - Negative
Peroxidase Hemoglobin
Leucocyte esterase Positive + - Negative
Enzymatic Reaction
Bilirubin Urine Negative - Negative
Coupling Reaction
Nitrite Negative - Negative
Griless Test
Urobilinogen Normal - Normal
Ehrlichs Test
Microscopic Examination
Pus Cells (WBCs) 8-10 /hpf 0-5
Epithelial Cells 4-6 /hpf 0-4
Red blood Cells Absent /hpf Absent
Crystals Absent - Absent
Cast Absent - Absent
Yeast Cells Absent - Absent
Amorphous deposits Absent - Absent
Bacteria Absent - Absent
Protozoa Absent - Absent
*** End Of Report ***

Page 10 of 11
Referred By : Self Barcode No : YA620449
Sample Type : Spot Urine Report Status : Final Report

Page 11 of 11
Terms and Conditions of Reporting
1. The presented findings in the Reports are intended solely for informational and interpretational purposes by the
referring physician or other qualified medical professionals possessing a comprehensive understanding of
reporting units, reference ranges, and technological limitations. The laboratory shall not be held liable for any
interpretation or misinterpretation of the results, nor for any consequential or incidental damages arising from
such interpretation.
2. It is to be presumed that the tests performed pertain to the specimen/sample attributed to the Customer's name
or identification. It is presumed that the verification particulars have been cleared out by the customer or his/her
representation at the point of generation of said specimen / sample. It is hereby clarified that the reports
furnished are restricted solely to the given specimen only.
3. It is to be noted that variations in results may occur between different laboratories and over time, even for the
same parameter for the same Customer. The assays are performed and conducted in accordance with standard
procedures, and the reported outcomes are contingent on the specific individual assay methods and equipment(s)
used, as well as the quality of the received specimen.
4. This report shall not be deemed valid or admissible for any medico-legal purposes.
5. The Customers assume full responsibility for apprising the Company of any factors that may impact the test
finding. These factors, among others, includes dietary intake, alcohol, or medication / drug(s) consumption, or
fasting. This list of factors is only representative and not exhaustive.
SMART HEALTH REPORT
RT
MC-5280
About Redcliffe Labs

We are India’s Most Trusted & Fastest Growing Network of Diagnostics Labs
Best Customer Quality Commitment Affordable Prices

Experience With Accurate Reports With Quick Results
Commitment to excellence, Focus on quality with Value for money with

high end technology oriented staff accurate results quick turn around time (TAT)
A step towards sustainable future

At Redcliffe Labs, we prioritize environmental sustainability. Please consider
the environmental impact before printing reports. If not essential, refrain
from printing to conserve paper and reduce our ecological footprint.
Select from a wide range of

Full Body Health Check-up
packages that suits your health
Best Selling Package
Annual Health Checkup

Advance Plus with Free HsCRP
Get free report consultation

& download our app
A Simple and easy way to track your health

3600 + Tests & Packages Presence in 220+ Cities
45 Min Express Sample 100% Accurate Report

Collection Guarantee.

Addfcfba 0eb4 11ef Ac47 7c1e520e223c Header

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Addfcfba 0eb4 11ef Ac47 7c1e520e223c Header

Uploaded by

Copyright:

Available Formats

Prepared For

Name Patient ID Gender Age

Everything looks good

Everything looks good

Everything looks good

Vital Screening Package

Booking Centre :- Home Collection

Booking Centre :- Home Collection

Erythrocyte Sedimentation Rate (ESR)

ESR - Erythrocyte Sedimentation Rate 12 mm/hr 0 - 19

AGE MALE FEMALE

Reference- Dacie and lewis practical hematology

Booking Centre :- Home Collection

Free Glucose Fasting Test

Glucose Fasting 100.7 mg/dL <100

Reference : American Diabetes Association

Booking Centre :- Home Collection

Vital Screening Package

Bilirubin Total 0.57 mg/dL 0.2 - 1.2

Booking Centre :- Home Collection

Kidney Function Test (KFT)

Blood Urea 24.06 mg/dL 21 - 43

Booking Centre :- Home Collection

Total Cholesterol 179 mg/dL <200

Risk Category A. CAD with > 1 feature of high risk group

Booking Centre :- Home Collection

Risk Group Treatment Goals Consider Drug Therapy

* After an adequate non-pharmacological intervention for at least 3 months.

Booking Centre :- Home Collection

Alpha Fetoprotein (AFP), Tumor Marker

AFP (ALPHA FETOPROTEIN), TUMOR MARKER 7.24 ng/mL Up to 8.78

Booking Centre :- Home Collection

Vital Screening Package

*** End Of Report ***

Booking Centre :- Home Collection

Booking Centre :- Home Collection

About Redcliffe Labs

Best Customer Quality Commitment Affordable Prices

Commitment to excellence, Focus on quality with Value for money with

A step towards sustainable future

Select from a wide range of

Best Selling Package

Annual Health Checkup

Get free report consultation

A Simple and easy way to track your health

45 Min Express Sample 100% Accurate Report

You might also like

* End Of Report *